CENTRAL TRUST Co lifted its position in Exelon Co. (NASDAQ:EXC – Free Report) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,401 shares of the company’s stock after acquiring an additional 600 shares during the quarter. CENTRAL TRUST Co’s holdings in Exelon were worth $391,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in EXC. Sanctuary Advisors LLC bought a new stake in shares of Exelon in the 2nd quarter worth about $1,215,000. Czech National Bank lifted its holdings in shares of Exelon by 6.9% in the 3rd quarter. Czech National Bank now owns 203,710 shares of the company’s stock worth $8,260,000 after acquiring an additional 13,173 shares during the last quarter. GAMMA Investing LLC increased its stake in Exelon by 29.7% in the 3rd quarter. GAMMA Investing LLC now owns 15,778 shares of the company’s stock worth $640,000 after buying an additional 3,616 shares during the period. Diversified Trust Co increased its stake in Exelon by 85.8% in the 3rd quarter. Diversified Trust Co now owns 37,517 shares of the company’s stock worth $1,521,000 after buying an additional 17,327 shares during the period. Finally, Marion Wealth Management purchased a new position in Exelon in the 3rd quarter worth about $226,000. Institutional investors own 80.92% of the company’s stock.
Exelon Stock Down 0.1 %
Shares of Exelon stock opened at $40.54 on Wednesday. The firm’s 50 day moving average price is $38.25 and its 200-day moving average price is $38.60. The company has a quick ratio of 0.97, a current ratio of 1.09 and a debt-to-equity ratio of 1.66. Exelon Co. has a 52-week low of $33.35 and a 52-week high of $41.19. The company has a market cap of $40.74 billion, a P/E ratio of 16.68, a PEG ratio of 2.66 and a beta of 0.56.
Insider Transactions at Exelon
Wall Street Analyst Weigh In
Several research firms recently commented on EXC. Barclays reduced their price target on shares of Exelon from $44.00 to $42.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 22nd. Scotiabank raised their price target on shares of Exelon from $40.00 to $42.00 and gave the stock a “sector perform” rating in a research note on Thursday, December 12th. Guggenheim raised shares of Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. Morgan Stanley reduced their price target on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Friday, November 22nd. Finally, Evercore ISI raised shares of Exelon from an “in-line” rating to an “outperform” rating and raised their target price for the company from $43.00 to $44.00 in a research report on Tuesday, January 21st. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $43.13.
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Further Reading
- Five stocks we like better than Exelon
- How to Capture the Benefits of Dividend Increases
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- With Risk Tolerance, One Size Does Not Fit All
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- 3 Dividend Kings To Consider
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.